Global Head of Intellectual Property, Paul Hastings
Joseph M. O’Malley, Jr., is the Global Head of Intellectual Property practice at Paul Hastings, overseeing the firm's 100 plus lawyer IP practice. He has extensive patent litigation experience across a broad range of technologies, including chemicals and pharmaceuticals. Mr. O'Malley has served as lead trial counsel for many branded pharmaceutical clients including Pfizer, Merck, Abbott, Eisai, Sepracor, and Nycomed, and has prevailed at trail and appeal in billion-dollar-a-year Hatch-Waxman Act pharmaceutical patent litigations.
Mr. O'Malley has been ranked as one of the top intellectual property attorneys in New York by Chambers USA every year since 2005; he has been listed as a "recommended" attorney in both PLC's Which Lawyer?: Intellectual Property and PLC's Which Lawyer?: Life Sciences every year since 2006, and has been recognized every year since 2007 in The Legal 500 US ranking of "leading lawyers in the field of patent litigation." Mr. O'Malley has been chosen as a New York Super Lawyer every year since 2006, and is a 2004 winner of the Burton Award for Legal Achievement.
Mr. O'Malley is widely quoted and published on a variety of topics relating to pharmaceutical patent litigation. His articles have appeared in both the mainstream media and in trade journals. Mr. O'Malley recently appeared on Bloomberg TV to discuss the growing trend of at-risk launches by generic pharmaceutical makers.
Prior to law school, Mr. O’Malley worked for seven years as a chemical engineer in DuPont’s engineering department. While at DuPont, Mr. O’Malley supervised the design and construction of new chemical and pharmaceutical processing facilities.
He received his J.D., with honors, from Rutgers-Camden School of Law, and his B.S. in chemical engineering, with highest honors, from Rutgers College of Engineering where he was a member of Tau Beta Pi (National Engineering Honor Society).